As GLP-1 use continues to grow, CRNAs are increasingly caring for patients taking these medications for weight loss, diabetes management, and emerging off-label uses. Learn the latest guidance on perioperative management, aspiration risk, medication screening, and other key considerations for delivering safe, evidence-based care.
